Sanofi SA
XHAM:SNW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sanofi SA
XHAM:SNW
|
FR |
|
E
|
Entergy Corp
DUS:ETY
|
US |
|
Applovin Corp
F:6RV
|
US |
|
E
|
Elis SA
F:7EL
|
FR |
|
E
|
Expeditors International of Washington Inc
DUS:EW1
|
US |
|
Wynn Resorts Ltd
F:WYR
|
US |
|
W
|
WEX Inc
F:WL9
|
US |
|
C
|
Cardiff Oncology Inc
SWB:XE7C
|
US |
|
M
|
Marchex Inc
F:NHM
|
US |
|
H
|
Holcim AG
XBER:HLBN
|
CH |
|
S
|
Samsung Electronics Co Ltd
LSE:SMSN
|
KR |
|
A
|
Accuray Inc
F:XEJ
|
US |
|
S
|
Stanley Black & Decker Inc
XBER:SWF
|
US |
|
Lindbergh SpA
F:D8M
|
IT |
|
Saipem SpA
F:SPE1
|
IT |
|
Brookfield Asset Management Inc
NYSE:BAM
|
CA |
Bankruptcy Probability
Sanofi SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sanofi SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Sanofi SA
PAR:SAN
|
89.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
535.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
206.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
277.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
148.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
36.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
919.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sanofi SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sanofi SA has total debt of 13.8B EUR. This includes both short-term (0 EUR) and long-term (13.8B EUR) debt.
You can find a full breakdown on its Balance Sheet.
